Measuring Prior Auth Efficiency: The KPIs That Actually Matter

Most practices know their prior auth process is painful. Few actually know how bad it is. They're running on gut feel — "we get a lot of denials" or "the payers are taking forever" — without the data to diagnose the real problem or track whether anything they try is working.

Seven metrics will tell you almost everything about your PA operation's health. Not 20. Not a dashboard that requires a consultant to interpret. Seven numbers, tracked consistently, will surface your biggest problems and show you where a fix is actually working.

KPI 1: First-Pass Approval Rate

What it is: The percentage of PA requests approved on the first submission, without an appeal or resubmission.

How to calculate it: Divide the number of cases approved on first submission by total submissions in the same period. Multiply by 100.

Industry benchmark: According to AMA survey data, the average first-pass approval rate across specialties hovers around 75–80%. For biologics specifically, it tends to run lower — often 65–70% — because the documentation requirements are more complex.

What good looks like: 85% or higher. Practices hitting 90%+ are usually doing two things right: strong clinical documentation upfront, and payer-specific submission formatting that pre-addresses the most common denial reasons.

What bad looks like: Below 70% almost always indicates a documentation problem, not a clinical one. The treatment is appropriate — the paper trail isn't making the case clearly enough.

This is the single most important number in your PA operation. Everything else flows from it.

KPI 2: Average Turnaround Time

What it is: The average number of business days between submission and receiving a decision (approval or denial).

How to calculate it: For each case, count business days from submission date to decision date. Average across all cases in the period.

Industry benchmark: The CAQH Index puts the average electronic PA turnaround at around 6 business days for commercial payers. Fax-based submissions average 10–14 days. Medicare Advantage plans are often faster due to CMS mandates — standard requests must be decided in 14 calendar days, expedited in 72 hours.

What good looks like: Under 6 business days for electronic submissions. Under 10 for fax. Consistently.

What bad looks like: High variance is as problematic as a high average. If your turnaround ranges from 2 days to 25 days, you have a follow-up and escalation problem — cases are sitting unworked somewhere in the pipeline.

KPI 3: Denial Rate by Payer

What it is: The percentage of submissions denied, broken out by individual payer — not as a single aggregate number.

How to calculate it: Denials from Payer X ÷ total submissions to Payer X × 100. Track this separately for your top 5–8 payers.

Why payer-level breakdown matters: An overall denial rate of 22% might look manageable. But that number could be hiding a 45% denial rate with one specific commercial plan — a plan whose documentation preferences differ from what you're submitting. Aggregate numbers mask actionable problems.

What good looks like: Under 15% with any individual payer. Over 25% with a specific payer is a clear signal to study their denial reasons and adjust your submission approach for that plan specifically.

This is one of the most underused KPIs in practice management. Most teams track overall denial rate. Breaking it down by payer is where the diagnosis gets specific enough to act on.

KPI 4: Appeal Success Rate

What it is: The percentage of denied cases that are successfully overturned through the appeals process.

How to calculate it: Cases overturned on appeal ÷ total cases appealed × 100.

Industry benchmark: A reasonable target is 40–60% for first-level appeals on biologics. External review (IRO appeals) has historically overturned insurance denials at rates above 60% in many states — a strong argument for pursuing appeals more aggressively than most practices do.

What good looks like: Above 45%, and trending upward as your appeals specialist gets more experienced with specific payer patterns.

What bad looks like: Under 30% almost always means one of three things: you're appealing unwinnable cases, your appeal letters aren't clinically specific enough, or you're missing the procedural requirements (submission deadlines, required attachments) that invalidate appeals before they're even reviewed.

KPI 5: Cost Per PA

What it is: The fully-loaded cost of processing one prior authorization, from intake to final decision.

How to calculate it: Add up total PA team compensation (including benefits), technology costs, and an allocation of physician time for peer-to-peers. Divide by monthly case volume.

Example: A coordinator at $48,000/year fully loaded, plus $200/month in software, plus 5 hours/month of physician time at $200/hour = approximately $5,200/month in costs. At 80 cases per month, that's $65 per case.

Industry benchmark: Manual PA processing costs an average of $11–$14 per transaction for commercial plans, per CAQH. But that number is a per-transaction average that doesn't capture the full loaded cost. When you include physician time, denial rework, and overhead allocation, the real cost is $40–$80 per case for specialty biologics.

Why this matters: Cost per PA is the denominator in your ROI calculation for any tool or process change. If you're spending $65 per case and a tool costs $1,800/month but cuts your time per case by 60%, you need to be running more than about 45 cases per month for it to pay for itself. The math is simple once you know your cost per case.

KPI 6: Staff Time Per Case

What it is: Average hours of staff time spent on each PA, from intake through final disposition.

How to calculate it: Time-track a sample of cases across your team for two weeks. Include intake, documentation, submission, follow-up calls, and rework on denials. Average the totals.

Industry benchmark: CAQH data puts the average manual PA at 20–45 minutes for a straightforward case. Biologics with step therapy documentation run closer to 45–75 minutes per case before any denial rework.

What good looks like: Under 30 minutes for a clean submission with strong documentation. Under 60 minutes including a denial rework cycle.

What bad looks like: Over 90 minutes per case almost always points to process fragmentation — staff hunting across EHR modules for clinical data, reformatting the same information multiple times, or rebuilding the clinical narrative from scratch for each payer rather than using templates.

This is the KPI most directly impacted by documentation automation. AI tools built specifically for prior auth documentation reduce time-per-case by 60–80% on the documentation assembly step alone — which is typically the longest single component of each case.

KPI 7: Patient Abandonment Rate

What it is: The percentage of patients who stop pursuing an approved treatment due to delays, prior auth hassle, or out-of-pocket costs triggered by coverage denials.

How to calculate it: Of all patients for whom a PA was initiated in a given period, what percentage never actually received the treatment? Track separately from cases where the PA was denied and no appeal was pursued.

Why this KPI gets skipped: It requires connecting your PA tracking data to your scheduling or encounter data — a step most teams never take because the two systems don't talk to each other. But this is where the hidden revenue loss lives.

Industry benchmark: Research on specialty drug abandonment consistently finds that 10–20% of patients abandon therapy when authorization delays stretch past two weeks. For biologics with $3,000–$15,000 per-treatment revenue impact, even a 5% abandonment rate is a material revenue problem.

What good looks like: Under 5%. Getting there requires both fast turnaround times and proactive patient communication when delays occur — patients who know what's happening are far less likely to disengage than patients who feel ignored.

How to Set Up Tracking Without Expensive Software

You can run a solid KPI tracking system with a well-structured spreadsheet until you're processing 60+ cases per month. The key columns: case ID, patient, drug/indication, payer, submission date, submission method (electronic vs. fax), decision date, decision (approved/denied/pending), appeal filed (yes/no), appeal outcome, and staff time logged.

From those fields, all seven KPIs calculate directly. Set up a monthly summary tab with the formulas. Review it the first Tuesday of every month with your PA team lead.

At 60+ cases per month, purpose-built PA management software earns its cost in visibility alone. Most platforms include built-in dashboards that surface these metrics automatically. The research on electronic prior authorization platforms consistently shows 40–60% reductions in processing time alongside measurably better tracking.

The Honest Benchmark

Here's a number most PA teams haven't seen: practices that actively track and optimize these seven metrics consistently outperform those that don't by 15–20 percentage points on first-pass approval rates. That's not from better clinical care. That's from knowing where the process breaks and fixing it specifically.

The measurement is the work. Start there.

Sources: American Medical Association, 2023 Prior Authorization Physician Survey (ama-assn.org); CAQH Index 2023, "Measuring the Progress of Electronic Health Care Administrative Transactions" (caqh.org); Health Affairs, "Administrative Costs Associated With Physician Billing and Insurance-Related Activities" (healthaffairs.org); Doshi JA et al., JAMA Internal Medicine, specialty drug abandonment research; National Center for Biotechnology Information, "Electronic Prior Authorization: Impact on Prescribing Efficiency" (ncbi.nlm.nih.gov).